Biotech / MedTech
Drylab raises $3M seed round to build AI research agents
Drylab AI, an autonomous agent platform for life sciences research, has raised $3 million in a seed round led by Vertex Ventures Southeast Asia & India, with participation from PatSnap.
TCGX closes $600M fund to invest in Asian biotech
TCGX has closed an oversubscribed $600 million fund to invest across stages in Asia-based biotechnology companies and is opening Hong Kong and Shanghai offices.
MetaGO’s Kunal Kapoor and Dr. Kaushal Patel on clinician-led digital GLP-1 care [Q&A]
MetaGO's Kunal Kapoor and Dr. Kaushal Patel discuss clinical oversight, health-data tracking, AI safeguards and long-term outcomes in digital GLP-1 care.
MIMS expands clinical decision-support platforms as it targets wider global growth
MIMS Group is expanding MIMS Pulse and eMIMS Plus across markets while growing its medical communications and AI-enabled content capabilities.
Alibaba DAMO unveils AI models for cancer and abdominal CT
Alibaba DAMO Academy has published research on EAGLE for esophageal cancer screening and RADAR for broad abdominal CT interpretation. Both remain research systems rather than approved clinical products.
GSK agrees to buy Chimagen cancer program in deal worth up to $750 million
GSK agreed to acquire global rights to a Chimagen multiple myeloma program in a deal with an undisclosed upfront fee and contingent payments totaling up to $750 million.
VVMF wins TGA license for Sydney viral vector facility
Australia’s VVMF has secured a TGA manufacturing license for its Westmead facility to produce specified viral vectors under GMP standards.
Merck expands biosafety testing laboratory in Singapore to strengthen services across Asia Pacific
Merck, a global science and technology company, is expanding its Singapore lab to further strengthen analytical and biosafety testing services for customers across the Asia Pacific region.
Singapore’s Tikva Allocell raises $8M in Series A financing led by Kantharos Capital
Tikva Allocell Pte. Ltd. (Tikva), a Singapore-based biotechnology company, has on Wednesday announced the closing of an $8 million Series A financing led by Kantharos Capital.
Singapore’s AngelCentral backs US biotech firm Rybodyn
Singapore-based investor AngelCentral announced Wednesday its first successful BioTech syndicate by its members to invest in RyboDyn Inc., a US biotechnology company pioneering the development of immunotherapies targeting the dark genome.
